Neuphoria Therapeutics (NEUP) Share-based Compensation (QoQ) (2023 - 2026)
Neuphoria Therapeutics (NEUP) Share-based Compensation (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Neuphoria Therapeutics | 21.37 Mn | 1.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.99% |
| Dec 31, 2025 | -15.79% |
| Sep 30, 2025 | -17.26% |
| Jun 30, 2025 | 557.16% |
| Mar 31, 2025 | -2.40% |
| Dec 31, 2024 | -21.57% |
| Sep 30, 2024 | -75.18% |
| Jun 30, 2024 | 169.08% |
| Mar 31, 2024 | -94.64% |
| Dec 31, 2023 | 431.82% |